Peggy Pinkston | VP, IR & Executive Director of Corporate Communications |
Clay Siegall | Co-Founder, Chairman, President & CEO |
Robin Taylor | Chief Commercial Officer |
Todd Simpson | CFO |
Roger Dansey | Chief Medical Officer |
Kennen MacKay | RBC Capital Markets |
Matthew Holt | JPMorgan Chase & Co. |
Michael Schmidt | Guggenheim Securities |
Andrew Berens | SVB Leerink |
Maryana Breitman | Goldman Sachs Group |
Gena Wang | Barclays Bank |
Tazeen Ahmad | Bank of America Merrill Lynch |
Stephen Willey | Stifel, Nicolaus & Company |
Shanshan Xu | Berenberg |
Andy Hsieh | William Blair & Company |
Silvan Tuerkcan | Oppenheimer |
Good day, ladies and gentlemen, and welcome to today's Seattle Genetics Second Quarter 2019 Financial Results Conference Call. Today's conference is being recorded.
For opening remarks, I'd like to turn the call over to Peggy Pinkston, Vice President of Investor Relations. Please go ahead.
Thank you, operator, and good afternoon, everyone.